Loading
Life sciences · Journal article
International Journal of Advanced Research · July 31, 2026
Raises a question worth testing. It does not answer one.
This is an exploratory in vitro screening study examining whether ethanolic extracts of Piper chaba inhibit growth of four bacterial pathogens in culture. The work raises the mechanistic question of whether this plant extract has antimicrobial properties but provides no evidence of efficacy in infection, no comparative potency data, and no basis for clinical translation.
In vitro antimicrobial susceptibility screening study. Four bacterial species: Escherichia coli, Staphylococcus aureus, Streptococcus pyogenes, and Klebsiella pneumoniae.. Intervention: Ethanolic extracts of Piper chaba at concentrations of 25%, 50%, 75%, and 100%..
Ethanolic extracts of Piper chaba were evaluated at four concentrations: 25%, 50%, 75%, and 100%. Antibacterial activity was assessed against four clinically important bacterial strains: Escherichia coli, Staphylococcus aureus, Streptococcus pyogenes, and Klebsiella pneumoniae. Antimicrobial activity measured by zone of inhibition diameter in millimetres.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
In vitro mechanistic study of a plant extract against bacterial strains with no clinical outcome, efficacy comparison, or translation to human infection.
As stated by the source record.
Quoted from the source exactly as published.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
The increasing prevalence of antimicrobial resistance among human pathogenic bacteria has emerged as a serious global health challenge, reducing the effectiveness of conventional antimicrobial therapies and creating an urgent need for the discovery of novel and effective antimicrobial agents. Indigenous medicinal plants have long been used in traditional systems of medicine for the treatment and management of various infectious diseases and are considered valuable sources of biologically active phytochemicals. The present study, entitled In-Vitro Anti-Microbial Potential of Indigenous Medicinal Plant Piper chaba Extracts Against Some Human Pathogenic Bacterial Strains, was conducted to investigate the In-Vitro antimicrobial potential of Piper chaba extracts against selected human pathogenic bacteria. The study aimed to evaluate the antibacterial activity of different concentrations of ethanolic extracts of Piper chaba against four clinically important bacterial strains, namely Escherichia coli, Staphylococcus aureus, Streptococcus pyogenes, and Klebsiella pneumoniae. The plant material was subjected to ethanolic extraction, and the resulting extract was evaluated at four different concentrations, namely 25%, 50%, 75%, and 100%, to determine the concentration-dependent antibacterial effects. The antimicrobial activity was assessed by measuring the diameter of the zone of inhibition (ZOI) produced against the selected bacterial strains and expressed in millimetres (mm).
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.